Improving Glycemic Control With Electrical Stimulation
Part of paid clinical trials in El Paso, Texas.
- Sponsor
- University of Texas, El Paso
- Study ID
- NCT03947697
- Status
- Recruiting
Conditions
- Insulin Resistance
- Obesity
- Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Neuromuscular Electrical Stimulation (Sensory) — DEVICEGroup will receive Electrical Stimulation up to sensory level
- Neuromuscular Electrical Stimulation — DEVICEGroup will receive Electrical Stimulation up to maximum tolerable level
- Resistance Training — OTHERGroup will receive exercise training.
Study Details
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=15 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Key Dates
- Start date
- Aug 9, 2022
- Status verified
- Aug 2024
- Primary completion
- Nov 25, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: ControlParticipants will receive stimulation only up to sensory level.
- Experimental: NMESParticipants will receive stimulation up to maximum tolerable level.
- Placebo Comparator: Resistance TrainingParticipants will receive exercise training with stimulation up to sensory level.
- Experimental: Resistance Training + NMESParticipants will receive exercise training with stimulation up to maximum tolerable intensity.
Primary Outcome Measure
Glycemic Control [ Time Frame: 8 weeks ]
Central Contacts
- Sudip Bajpeyi, PhD9157475461
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas at El Paso | El Paso | Texas | 79968 | Michelle Galvan, B.S. (SUB_INVESTIGATOR) Jehu N Apaflo, M.S. (SUB_INVESTIGATOR) Gabriel Narvaez, B.S. (SUB_INVESTIGATOR) |
Find similar trials in El Paso, TX
Related Studies
- Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- RESET System Pivotal Trial (Rev F)Recruiting · Morphic Medical Inc. · Washington D.C., District of Columbia
- Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)EARLY_PHASE1 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Effects of Obesity in the AgedRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas